Janssen BioTech | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,967 results for “Janssen BioTech”

Trials

View all 177 →

Post-Procedural Biotech Cellulose Mask

15 participants · First posted Oct 3, 2023

Provigil (Modafinil) Study by Taiwan Biotech Co.

30 participants · First posted Sep 15, 2005

Janssen - Glucose Regulation/Risp/Olanz

120 participants · First posted Sep 20, 2005

Drugs

View all 873 →

Bispecific antibodies to gamma-delta T cells therapy (Janssen Biotech / Lava Therapeutics)

Monoclonal antibody G250RIT

BRM-211

Organizations

View all 330 →

JANSSEN BIOTECH, INC.

United States

MorphoSys

Germany

JANSSEN CILAG

France

News

View all 3587 →

CHMP Recommends Amivantamab Plus Lazertinib for First-Line EGFR-Mutated NSCLC

Yuhan Corporation Receives $15 Million Milestone from Janssen Following Japan Launch of Lazertinib-Amivantamab Combination for EGFR-Mutated NSCLC

FDA Approves Pyzchiva (ustekinumab-ttwe), Biosimilar to Stelara, for Inflammatory Conditions

Page 1 of 497